Accessibility Menu
Zynex logo

Zynex

(NASDAQ) ZYXI

This security has been delisted. This page is retained for historical reference.

Zynex last closing stock price
MetricPriceDate
Last closeUSD 0.062026-03-26
Zynex stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-23.02%USD 0.072026-03-19
1 month-36.05%USD 0.092026-02-24
3 month-19.12%USD 0.072025-12-26
Year to date-56.35%USD 0.132025-12-31
1 year-99.25%USD 7.342019-07-24
3 year-99.25%USD 7.342019-07-24
5 year-99.25%USD 7.342019-07-24
Since inception-95.22%USD 1.152004-02-12

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

ZYXI Financials

Key Financial Metrics (TTM)

Gross Margin

66.73%

Operating Margin

-108.22%

Net Income Margin

-117.86%

Return on Equity

1137.87%

Return on Capital

5.47%

Return on Assets

-161.83%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$77.51M

Operating Income

-$67.91M

EBITDA

-$64.31M

Operating Cash Flow

-$20.57M

Capital Expenditure

-$431.00K

Free Cash Flow

-$21.00M

Cash & ST Invst.

$13.26M

Total Debt

$71.62M

Zynex Performance Analysis

Zynex annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 130,301,000N/A
20222022-12-31USD 158,167,00021.4%
20232023-12-31USD 184,322,00016.5%
20242024-12-31USD 192,354,0004.4%
Zynex sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-8.0%
Q12025-03-31-42.2%
Q22025-06-30-16.1%
Q32025-09-30-40.1%
Zynex annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD 0.40N/A
20222022-12-31USD 0.449.8%
20232023-12-31USD 0.27-38.2%
20242024-12-31USD 0.09-65.6%
Zynex sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-125.7%
Q12025-03-31-1627.7%
Q22025-06-30-100.0%
Q32025-09-30-115.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$13.36M

-73.3%

Gross Profit

$8.08M

-79.7%

Gross Margin

60.47%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

1,000

N/A

Net Income

-$42.91M

-1901.6%

EBITDA

-$43.91M

-993.5%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Total Cash

$13.26M

-64.8%

Total Debt

$71.62M

-4.1%

Accounts Receivable

$6.70M

-69.0%

Inventory

$11.99M

-23.7%

Long Term Debt

$7.85M

-88.9%

Short Term Debt

$63.77M

+1395.9%

Return on Assets

-1.62%

N/A

Return on Invested Capital

2.01%

N/A

Free Cash Flow

-$6.33M

-190.3%

Operating Cash Flow

-$6.31M

-189.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MODDModular Medical, Inc.
$2.71-9.06%
HYPDHyperion DeFi, Inc.
$2.83+3.10%
EVAXEvaxion Biotech A/S
$3.00-2.44%
GBIOGeneration Bio Co.
$5.34+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$98.61+0.04%
HLHecla Mining
$14.38+0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.94-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$68.98+0.02%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.